SCHEMBL6348319

SCHEMBL6348319

O=C(Nc1ccc(Cl)cc1C(=O)O)c1cccc(/C(=N\O)c2ccco2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.60
▸ CYP2C19 P33261 2/20 0.60
▸ CYP3A4 P08684 1/20 0.60
▸ CYP2C9 P11712 1/20 0.60
▸ AKR1C4 P17516 1/20 0.60
▸ AKR1C3 P42330 1/20 0.60
▸ AKR1C2 P52895 1/20 0.60
▸ AKR1C1 Q04828 1/20 0.60
▸ SERPINE1 P05121 9/20 0.57
▸ CA9 Q16790 2/20 0.53
▸ CA12 O43570 1/20 0.53
▸ CA1 P00915 1/20 0.53
▸ CA2 P00918 1/20 0.53
▸ CA7 P43166 1/20 0.53
▸ ALDH1A1 P00352 2/20 0.52
▸ HPGD P15428 2/20 0.52
▸ ALOX15 P16050 2/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ POLB P06746 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6348324 1.00 CYP1A2 (0.60) CYP1A2CYP2C19CYP3A4CYP2C9AKR1C4
SCHEMBL6353139 0.88 CYP1A2 (0.56) CYP1A2CYP2C19CYP3A4CYP2C9AKR1C4
SCHEMBL6353138 0.88 CYP1A2 (0.56) CYP1A2CYP2C19CYP3A4CYP2C9AKR1C4
SCHEMBL6360629 0.87 CYP1A2 (0.68) CYP1A2CYP2C19CYP3A4CYP2C9AKR1C4
SCHEMBL6359750 0.80 SERPINE1 (0.71) CYP1A2CYP2C19CYP3A4CYP2C9AKR1C4
SCHEMBL6358679 0.79 AKR1C4 (0.60) AKR1C4AKR1C3AKR1C2AKR1C1SERPINE1
SCHEMBL6358675 0.79 AKR1C4 (0.60) AKR1C4AKR1C3AKR1C2AKR1C1SERPINE1
SCHEMBL6353083 0.78 CYP1A2 (0.56) CYP1A2CYP2C19CYP3A4CYP2C9SERPINE1
SCHEMBL6353081 0.78 CYP1A2 (0.56) CYP1A2CYP2C19CYP3A4CYP2C9SERPINE1
SCHEMBL6349319 0.76 SERPINE1 (0.85) AKR1C4AKR1C3AKR1C2AKR1C1SERPINE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 — — US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 CYP1A2 2118/4885CYP2C19 1614/4885CYP3A4 2255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback